MedPath

Success Rate Natural Cycles Versus Modified Natural Cycles in Frozen Embryos

Conditions
Infertility, Female
Registration Number
NCT03798886
Lead Sponsor
Acibadem University
Brief Summary

There has been a recent significant increase in the frozen embryo replacement (FER) cycles due to freeze-all cycles to decrease the risk of ovarian hyperstimulation syndrome. Now a days making frozen embryo transfers (FETs) a viable alternative to fresh embryo transfer

Detailed Description

There has been a recent significant increase in the frozen embryo replacement (FER) cycles due to freeze-all cycles to decrease the risk of ovarian hyperstimulation syndrome. Now a days making frozen embryo transfers (FETs) a viable alternative to fresh embryo transfer, with reports from observational studies and randomized controlled trials suggesting that:

1. The endometrium in stimulated cycles is not optimal for implantation

2. Pregnancy rates are increased following FET

3. Perinatal outcomes are less affected after FET

4. Preimplantation genetic screening We will follow only natural and modified natural cycles patients. Spontaneous ovulation will documented with hormonal and sonographic monitoring. Hormonal monitoring are including estradiol and luteinizing hormone (LH). Sonographic monitoring is including follicule diameter (16-20 mm). At modified natural cycles we will use hCG triggering for ovulation approximately 16-20 mm diameter.

We will compare success rate between natural and modified natural cycles

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Patient who are admitted to the IVF center and who will be transferred to frozen embryos.
  • Infertile women under 40 years of age who accepted this study.
  • Unexplained infertilite couple.
  • All ovulatory patient.
  • Male factor.
  • Tubal factor.
Exclusion Criteria
  • Patients who made intrauterin surgery.
  • Over 40 years of age women.
  • Patients with preimplantation genetic diagnosis.
  • Anovulatory patient.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
birthbigger than 24 weeks pregnancy

live birth

Secondary Outcome Measures
NameTimeMethod
pregnancy rate10th day after embryo transfer

hcg blood test

abortion rate8 weeks

abortion after visualization of fetal cardiac activity

clinical pregnancy rate8 weeks

positive fetal cardiac activity

Trial Locations

Locations (1)

Acibadem MAA University Atakent Hospital

🇹🇷

Istanbul, Turkey

Acibadem MAA University Atakent Hospital
🇹🇷Istanbul, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.